Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study

被引：0
|
作者：
Jamie Carter
Zhen Li
Hillary Chen
Melissa Greiner
Christopher Bush
Debanjan Bhattacharya
Stephanie Poley
Nidhi Sachdeva
Jane Carolyn Crowder
Jacob Feigal
机构：
[1] Lincoln Community Health Center,Department of Population Health Sciences
[2] Duke University School of Medicine,Department of Psychiatry and Behavioral Sciences
[3] Duke University School of Medicine,Department of Medicine
[4] Duke University School of Medicine,undefined
来源：
Addiction Science & Clinical Practice | / 17卷
关键词：
Opioid use disorder; Medication for opioid use disorder; Buprenorphine; Harm reduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] LOW BARRIER MEDICATION FOR OPIOID USE DISORDER AT A FEDERALLY QUALIFIED HEALTH CENTER: A RETROSPECTIVE COHORT STUDY
    Carter, Jamie
    Chen, Hillary
    Li, Zhen
    Greiner, Melissa
    Bush, Christopher
    Bhattacharya, Debanjan
    Sachdeva, Nidhi
    Feigal, Jacob
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (SUPPL 2) : 155 - 155
  • [2] Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study
    Carter, Jamie
    Li, Zhen
    Chen, Hillary
    Greiner, Melissa
    Bush, Christopher
    Bhattacharya, Debanjan
    Poley, Stephanie
    Sachdeva, Nidhi
    Crowder, Jane Carolyn
    Feigal, Jacob
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2022, 17 (01)
  • [3] IMPLEMENTATION OF A LOW BARRIER MODEL OF MEDICATION FOR OPIOID USE DISORDER AT A FEDERALLY QUALIFIED HEALTH CENTER: A QUALITATIVE STUDY
    Carter, Jamie
    Chen, Hillary
    Marais, Andrea Des
    Sachdeva, Nidhi
    Feigal, Jacob
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (SUPPL 2) : 149 - 149
  • [4] Medication for Opioid Use Disorder in Federally Qualified Health Centers
    Lindenfeld, Zoe
    Mauri, Amanda I.
    JAMA NETWORK OPEN, 2025, 8 (01)
  • [5] Checkup Visits in Adult Federally Qualified Health Center Patients: a Retrospective Cohort Study
    Liss, David T.
    Yang, Ta-Yun
    Hamielec, Magdalena
    Mcauliff, Kathleen
    Rusie, Laura K.
    Mohanty, Nivedita
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (08) : 1378 - 1385
  • [6] Nine-year substance use treatment outcomes with buprenorphine for opioid use disorder in a federally qualified health center
    Haddad, Marwan
    Coman, Emil
    Bifulco, Lauren
    DRUG AND ALCOHOL DEPENDENCE, 2024, 257
  • [7] Barriers to medication error reporting in a federally qualified health center
    Witt, Jessica M.
    Cillessen, Lisa M.
    Gubbins, Paul O.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2024, 64 (04)
  • [8] Integration of a Community Opioid Treatment Program Into a Federally Qualified Health Center
    Neeb, Christine
    McQuade, Brianna M.
    Lesondak, Linda
    Madrid, Samantha
    Schlaeger, Judith M.
    Watson, Dennis P.
    Karnik, Niranjan
    Huerta, Noami
    Bhatia, Simar
    Fleurimont, Judes
    Li, Nicole
    Hammerdahl, Elsa
    Pesantez, Ricky
    Gastala, Nicole
    JOURNAL OF ADDICTION MEDICINE, 2024, 18 (06) : 663 - 669
  • [9] DEVELOPMENT AND IMPLEMENTATION OF AN OPIOID SAFETY CLINIC IN A FEDERALLY QUALIFIED HEALTH CENTER
    Binswanger, Ingrid A.
    Joseph, Nicole
    Hanratty, Rebecca
    Whitson, Valerie
    Witte, Amy J.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S875 - S876
  • [10] Evaluation of medication adherence in chronic disease at a federally qualified health center
    Oung, Alvin B.
    Kosirog, Emily
    Chavez, Benjamin
    Brunner, Jason
    Saseen, Joseph J.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2017, 8 (8-9) : 113 - 120
12345